Heart Failure: Part 1

Survival Prospects of Contemporary GUCH Patients: Is Heart Failure the New Threat?
Barbara Mulder, The Netherlands

mulder picBarbara JM Mulder is Professor of Cardiology in the Academic Medical Center in Amsterdam, the Netherlands. In 2001 she initiated the national registry and DNA bank for congenital heart disease, named CONCOR ( CONgenital CORvitia), in which presently over 16.000 patients have been included. She chaired the European Heart Survey on congenital heart disease with 79 participating centers from 24 countries.. From 2010 until 2012 she was president of the International Society of Adult Congenital Cardiology, ISACHD. At present, she is the president of the Netherlands Society of Cardiology


State of the Art of Heart Failure Treatment in GUCH Patients
Werner Budts, Belgium



Heart Failure: Ask the Experts: Part 2


How would you Treat this Patient?
Case Presenter: Matthias Greutmann, Switzerland
Expert Panel: Karen Stout, USA; John Deanfield, UK, Gruschen Veldtman, USA

Failing Fontan with Protein-Loosing Enteropathy

ccTGA with Moderate Tricuspid Regurgitation and Heart Failure

Pregnant CHD with Heart Failure



Rapid Fire Session: Therapeutic Innovations: Ready for the GUCH Patient


Subcutaneous ICD and Life Vest
Haran Burri, Switzerland



Leadless Pacing
Christof Kolb, Germany



TAVI for the Bicuspid Aortic Valve
Stephan Windecker, Switzerland



Percutaneous Repair of the Tricuspid Valve: On the Horizon?
Francesco Maisano, Switzerland



Assist Devices for the Failing Systemic Right Ventricle
David Crossland, UK

Crossland photo


Overcoming Treatment Challenges in CHD-PAH Patients
Presentation and Discussion of Two Challenging Clinical Cases


Never Too Old to be Treated?
Dr. Alexandra C. van Dissel
Academic Medical Center, Amsterdam, The Netherlandsvan Dissel, alexandra photo



New Drug Therapies for GUCH Patients


Angiotensin Receptor-Neprilysin Inhibitors in Heart Failure from CHD
Karen Stout, USA




Barbara Mulder, The Netherlands



Pulmonary Vasodilators in Fontan Patients
Maurice Beghetti, Switzerland



Can we use the New Pulmonary Vasodilators also in Eisenmenger?
Gerhard Diller, Germany



Oral Anticoagulation: In Whom, When and How?


Stroke in Adults with CHD: Incidence and Cumulative Risks
Sara Thorne, UK



Can we use CHADS-VASC and HAS-BLED Scores to Risk Stratify GUCH Patients
Jolien W. Roos-Hesselink, The Netherlands


Which GUCH Patient with IART Needs Long Term Anticoagulation
Judith Bouchardy, Switzerland



Which Adult Fontan Patient Needs Anticoagulation
Gruschen Veldtman,



Which Cyanotic Patient needs Anticoagulation
Erwin Oechslin, Canada

Oechslin December 2008 picDr. Erwin Oechslin is Professor of Medicine at the University of Toronto and Director of the Adult Congenital Heart Disease Program, located at the Peter Munk Cardiac Center, University Health Network, Toronto, Canada.

Dr. Erwin Oechslin was born in Einsiedeln (Switzerland) and graduated from the University of Zurich. After completion of his training in internal medicine and adult cardiology, he dedicated his education to congenital heart disease, which included one year training in pediatric cardiology at the Hospital for Sick Children in Zurich (Switzerland) and a two-year fellowship in Adult Congenital Heart Disease under the supervision of Dr. Gary Webb, Toronto. He returned to the University of Hospital of Zurich in 1998 and restructured the Adult Congenital Heart Disease Program.

He moved to Toronto, Canada, in 2006 and succeeded Dr. Gary Webb as Director of the Adult Congenital Heart Disease Program. He holds the Bitove Family Professorship of Adult Congenital Heart Disease and serves as staff physician in the echo laboratory. He is President of the International Society of Adult Congenital Heart Disease ( and Past-President of the CACH Network ( He is married to Doris and has three daughters.



Jane Somerville Lecture


The Olympic Spirit in GUCH
John Deanfield, UK


Rapid Fire Session: Difficult Questions in Simple Lesions



A Surgically Closed ASD II in Childhood: Completely Corrected?
Alexander Kadner, Switzerland




Hypertension in Repaired Coarctation: When to Intervene and How to Treat?
Andreas Eicken, Germany



Family Screening in Bicuspide Aortic Valves: Really Necessary?
Julie De Backer, Belgium




Marfan = Sartan?
Romy Franken, The Netherlands




RCA from the Left Coronary Sinus: Who needs Surgery?
René Pretre, Switzerland




The Dilated PA: Is there a Risk of Dissection?
Pastora Gallego, Spain





Bicuspid Aortic Valve: Operate Every Aorta at 5 cm
Pro: Alessandro Giamberti, Italy
Con: Markus Schwerzmann, Switzerland




Every Fallot with Severe Pulmonary Regurgitation needs a New Valve
Pro: Werner Budts, Belgium
Con: Matthias Greutmann, Switzerland


Rapid Fire Session: Simple Questions in Complex Lesions


Everything is Good in Arterial Switches?
Daniel Tobler, Switzerland




I’m a Fontan Patient and want to get Pregnant: Any Concerns?
Lorna Swan, UK




The Adult Fontan Patient with Suspected Hepatic Fibrosis: Do we need Liver Biopsies?
Gruschen Veldtman, USA




Low-Flow Low-Gradient Pulmonary Stenosis in Repaired TOF: Fact or Fiction?
Helmuth Baumgartner, Germany




TPV Options for RVOT Patients


Melody TPV: Past, Present and Future
Dr. Andreas Eicken, Germany




GUCH: Technical Options & Solutions
Prof. Oliver Kretschmar, Switzerland




Living with a Heart Defect


Prescribing PDE-5-Inhibitors for Erectile Dysfunction: Safe in GUCH Patients?
Gerhard Diller, Germany



Lets Talk about Sex
Claudia Franke, Germany




Piercing and Tattoos: A Threat for our Patients?
Philip Moons, Belgium




Depression and Suicide among GUCH Patients: Never Heard of?
Adrienne Kovacs, USA



Sports and GUCH


Competitive Sport with a Dilated Aorta: Really Dangerous?
Christian Schmied, Switzerland




Sudden Cardiac Death in GUCH Patients during Activity: Who is Really at Risk?
Dipen Shah, Switzerland



I want to Dive with my Heart Defect: Any Concerns?
Martin Kraus, Switzerland



The New ACC Recommendations for Competitives Athletes with CHD: Sense or Nonsense?
Harald Gabriel, Austria



Closing Session: Best Abstract Awards


Third Prize – Short Presentation by Winner: High Pulmonary Wedge Pressures Independently Predict Atrial Fibrillation in Patients after Trans-Catheter Closure of Atrial Septal Defect
Lukas Mark Meier, Canada




Second Prize – Short Presentation by Winner: Collagen Turnover Biomarkers and Systemic Right Ventricle Remodeling in Adults with Previous Atrial Switch Procedure for Transposition of the Great Arteries
Magdalena Lipczynska, Poland 




First Prize – Short Presentation by Winner: Characteristics and Outcomes of Heart Failure-related Hospitalization in Adults with Congenital Heart Disease
Magalie Ladouceur, France